Understanding epidemiological and clinical study designs is key to producing reliable health evidence. From descriptive reports to randomized trials, each design has unique strengths and limitations.

The timing of myocarditis onset during immunotherapy treatment for cancer may predict how likely a person is to die of the condition, according to retrospective study results.Patients who developed my ...

Researchers evaluated contraceptive use, gynecologic follow-up, and pregnancy risk awareness among women with various rheumatic conditions.

Objectives Lesbian, gay, bisexual and transgender (LGBT) individuals have faced marginalisation and discrimination despite ...

Patients who developed myocarditis within the first month of receiving immune checkpoint inhibitor therapy were more likely to die of myocarditis, and myocarditis-specific fatality was more common in ...

This evidence gap creates real challenges for pregnant women managing health conditions who may choose or be advised to ...

Street medicine is rapidly expanding in the United States, but realizing its potential to improve health outcomes will ...

Patients who developed myocarditis within the first month of receiving immune checkpoint inhibitor therapy were more likely to die of myocarditis, and myocarditis-specific fatality was more common in ...

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women. The 2023 International Evidence-based ...

A new review in Science China Life Sciences examines how machine learning and host-microbiome multi-omics can be combined to better understand health and disease. The article outlines the road from ...

Model-based systems engineering (MBSE) has been around for a while, but it continues to gain ground in engineering projects ...

Objectives Over the last decade, a growing number of health interventions (eg, medical assistance in dying and mitochondrial ...